These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 38703073)
21. Overcoming cancer risk in inflammatory bowel disease: new insights into preventive strategies and pathogenesis mechanisms including interactions of immune cells, cancer signaling pathways, and gut microbiota. Zhang H; Shi Y; Lin C; He C; Wang S; Li Q; Sun Y; Li M Front Immunol; 2023; 14():1338918. PubMed ID: 38288125 [TBL] [Abstract][Full Text] [Related]
22. Microbiota dysbiosis and barrier dysfunction in inflammatory bowel disease and colorectal cancers: exploring a common ground hypothesis. Yu LC J Biomed Sci; 2018 Nov; 25(1):79. PubMed ID: 30413188 [TBL] [Abstract][Full Text] [Related]
23. Colonic Mucosal Microbiota and Association of Bacterial Taxa with the Expression of Host Antimicrobial Peptides in Pediatric Ulcerative Colitis. Jalanka J; Cheng J; Hiippala K; Ritari J; Salojärvi J; Ruuska T; Kalliomäki M; Satokari R Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32842596 [TBL] [Abstract][Full Text] [Related]
24. Transplantation of bacteriophages from ulcerative colitis patients shifts the gut bacteriome and exacerbates the severity of DSS colitis. Sinha A; Li Y; Mirzaei MK; Shamash M; Samadfam R; King IL; Maurice CF Microbiome; 2022 Jul; 10(1):105. PubMed ID: 35799219 [TBL] [Abstract][Full Text] [Related]
25. Dysplasia and colorectal cancer in inflammatory bowel disease: a result of inflammation or an intrinsic risk? Breynaert C; Vermeire S; Rutgeerts P; Van Assche G Acta Gastroenterol Belg; 2008; 71(4):367-72. PubMed ID: 19317276 [TBL] [Abstract][Full Text] [Related]
26. 5-aminosalicylate is not chemoprophylactic for colorectal cancer in IBD: a population based study. Bernstein CN; Nugent Z; Blanchard JF Am J Gastroenterol; 2011 Apr; 106(4):731-6. PubMed ID: 21407180 [TBL] [Abstract][Full Text] [Related]
27. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease. Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187 [TBL] [Abstract][Full Text] [Related]
28. Gut microbiota in mucosa and feces of newly diagnosed, treatment-naïve adult inflammatory bowel disease and irritable bowel syndrome patients. Čipčić Paljetak H; Barešić A; Panek M; Perić M; Matijašić M; Lojkić I; Barišić A; Vranešić Bender D; Ljubas Kelečić D; Brinar M; Kalauz M; Miličević M; Grgić D; Turk N; Karas I; Čuković-Čavka S; Krznarić Ž; Verbanac D Gut Microbes; 2022; 14(1):2083419. PubMed ID: 35695669 [TBL] [Abstract][Full Text] [Related]
29. Inflammatory bowel disease: between genetics and microbiota. Younis N; Zarif R; Mahfouz R Mol Biol Rep; 2020 Apr; 47(4):3053-3063. PubMed ID: 32086718 [TBL] [Abstract][Full Text] [Related]
30. [Research advance on the interaction between gut microbes and cytokines in inflammatory bowel disease]. Lu X; Zhang S; Li X; Li H Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2024 Jul; 40(7):655-659. PubMed ID: 39179410 [TBL] [Abstract][Full Text] [Related]
31. 5-Aminosalicylic acid and chemoprevention: does it work? Lopez A; Peyrin-Biroulet L Dig Dis; 2013; 31(2):248-53. PubMed ID: 24030235 [TBL] [Abstract][Full Text] [Related]
32. Risk of colorectal cancer in inflammatory bowel diseases. Nadeem MS; Kumar V; Al-Abbasi FA; Kamal MA; Anwar F Semin Cancer Biol; 2020 Aug; 64():51-60. PubMed ID: 31112753 [TBL] [Abstract][Full Text] [Related]
33. The Intestinal Microbiota in Inflammatory Bowel Disease. Becker C; Neurath MF; Wirtz S ILAR J; 2015; 56(2):192-204. PubMed ID: 26323629 [TBL] [Abstract][Full Text] [Related]
34. Functional Characterization of Inflammatory Bowel Disease-Associated Gut Dysbiosis in Gnotobiotic Mice. Nagao-Kitamoto H; Shreiner AB; Gillilland MG; Kitamoto S; Ishii C; Hirayama A; Kuffa P; El-Zaatari M; Grasberger H; Seekatz AM; Higgins PD; Young VB; Fukuda S; Kao JY; Kamada N Cell Mol Gastroenterol Hepatol; 2016 Jul; 2(4):468-481. PubMed ID: 27795980 [TBL] [Abstract][Full Text] [Related]
35. Eosinophils in the gastrointestinal tract and their role in the pathogenesis of major colorectal disorders. Loktionov A World J Gastroenterol; 2019 Jul; 25(27):3503-3526. PubMed ID: 31367153 [TBL] [Abstract][Full Text] [Related]
36. Helicobacter pylori infection and inflammatory bowel disease: is there a link? Papamichael K; Konstantopoulos P; Mantzaris GJ World J Gastroenterol; 2014 Jun; 20(21):6374-85. PubMed ID: 24914359 [TBL] [Abstract][Full Text] [Related]
37. Microbiota and IBD: Current knowledge and future perspectives. Foppa C; Rizkala T; Repici A; Hassan C; Spinelli A Dig Liver Dis; 2024 Jun; 56(6):911-922. PubMed ID: 38008696 [TBL] [Abstract][Full Text] [Related]
38. Taxonomic and phenotypic analysis of bifidobacteria isolated from IBD patients as potential probiotic strains. Bosselaar S; Dhelin L; Dautel E; Titecat M; Duthoy S; Stelmaszczyk M; Delory N; De Sousa Violante M; Machuron F; Ait-Abderrahim H; Desreumaux P; Foligné B; Monnet C BMC Microbiol; 2024 Jun; 24(1):233. PubMed ID: 38951788 [TBL] [Abstract][Full Text] [Related]
39. Gut microbiota in the pathogenesis of inflammatory bowel disease. Nishida A; Inoue R; Inatomi O; Bamba S; Naito Y; Andoh A Clin J Gastroenterol; 2018 Feb; 11(1):1-10. PubMed ID: 29285689 [TBL] [Abstract][Full Text] [Related]
40. Microbiota dysbiosis in inflammatory bowel diseases: in silico investigation of the oxygen hypothesis. Henson MA; Phalak P BMC Syst Biol; 2017 Dec; 11(1):145. PubMed ID: 29282051 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]